Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1
Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin
- Status
- UNKNOWN
- Phase
- PHASE4
Enhancing a Sustainable Pharmacy-based Immunization Program in Two States
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications
- Status
- COMPLETED
- Phase
- NA
Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083)
- Status
- COMPLETED
- Phase
- PHASE2
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Outcomes and Cost of Gram Negative Bacteremia
- Status
- COMPLETED
- Phase
- N/A
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
- Status
- COMPLETED
- Phase
- NA
The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
- Status
- COMPLETED
- Phase
- NA
MRI and PET to Assess Pembrolizumab Response
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2